Gait disorders and slowed walking speeds may be useful indicators of future cognitive decline, reveals a new study.
Simple gait testing can identify older adults with cognitive impairments, reports a new study. The findings of the study are published in the Journal of Alzheimer's Disease. // "There is an emerging focus on the importance of assessing motor performance as well as cognitive performance to predict cognitive function loss," explained guest editor Manuel Montero-Odasso, MD, PhD, Departments of Medicine (Geriatric Medicine), and Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, University of Western Ontario, and Gait and Brain Lab, Parkwood Institute, Lawson Health Research Institute, London, ON, Canada.
‘Gait may be present at the early stages of dementia. Hence, the way people walk may be an indicator of how much their brains are aging.
’
"In the past two decades, large epidemiological studies have shown that gait disorders, particularly slowing gait, may be present at early stages of dementia or may even predict who will be at risk of progressing to dementia. Subtle impairments in gait are more prevalent in older adults with cognitive impairments and dementia and are also associated with an increased risk of falls." This supplement presents a comprehensive assessment of the current state of knowledge on the role of gait disturbances and quantitative gait analyses to be used as a motor biomarker to define subtypes of cognitive profiles and predict cognitive decline and dementia. It also evaluates screening tools that are important for developing strategies to prevent or delay the onset of clinically meaningful change.
The issue showcases studies on:
- Epidemiology of gait disturbances and cognitive impairment
- Association between gait speed and further cognitive decline
- Structural brain volume covariance and its association with gait speed in patients with mild cognitive decline
- Association of cerebral amyloid-beta deposition and impaired gait speed and lower extremity function
- Use of the dual-task gait (DTG) paradigm of walking while performing a concurrent cognitively demanding task as a brain stress test to detect populations at risk
- Value of DTG to detect individuals at risk of cognitive decline in a cognitively healthy population of older adults
- Associations between DTG performance and cerebrospinal biomarkers of AD
- Effect of learning to use a mobility aid on gait and cognitive demands in AD - the use of assistive devices can help improve mobility and reduce the risk of falls but can also present a cognitive challenge
- Feasibility of measuring gait in an outpatient cognitive neurology setting
Gait testing may help to detect the subgroup of at-risk patients who may benefit the most from invasive diagnostic procedures or early interventions. "We believe simple gait testing should be part of routine clinical assessment for older adults with cognitive impairments. Implementing this in clinics may be a challenge, but we hope the evidence presented in this issue will lead to progress in this area," noted guest editor George Perry, Ph.D., Editor-in-Chief of JAD, Professor of Biology, Semmes Distinguished University Chair in Neurobiology, The University of Texas at San Antonio, TX, USA.
Advertisement
Cognitive impairment and dementia carry a heavy healthcare burden. Around fifty million people worldwide have dementia. Every year there are nearly ten million new cases. AD is the most common form, accounting for around 60-70 percent of cases.
Advertisement
Source-Eurekalert